Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial

OBJECTIVE: To compare patient reported measures of function, health related quality of life (QoL), and satisfaction with medication among patients with rheumatoid arthritis (RA) treated with methotrexate (MTX), etanercept, or both for up to 1 year. METHODS: In a 52 week, double blind, clinical trial...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: van der Heijde, D, Klareskog, L, Singh, A, Tornero, J, Melo‐Gomes, J, Codreanu, C, Pedersen, R, Freundlich, B, Fatenejad, S
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Group 2006
Ämnen:
Extended Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1798055/
https://ncbi.nlm.nih.gov/pubmed/16079172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2005.035709
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk